CAESAREA, Israel, May 9, 2017 /PRNewswire/ -- DarioHealth Corp.
(NASDAQ: DRIO), a leading global digital health company with mobile
health and big data solutions, today announced that it will release
its first quarter 2017 results on Monday,
May 15 and host a conference call at 9:00am ET. The Company will discuss its first
quarter 2017 operating and financial results and its strategy and
outlook for 2017. The conference call will be hosted by
Erez Raphael, Chief Executive
Officer, and Zvi Ben-David, Chief
Financial Officer. The live conference call can be accessed by
dialing (866) 682-6100 or (862) 255-5401. Participants should ask
for the DarioHealth Earnings Conference Call. The conference call
will also be available via live webcast at:
http://www.investorcalendar.com/IC/CEPage.asp?ID=175941
Conference Call Details:
Date: Monday, May 15, 2017
Time: 9:00AM ET
Dial-in Number: (866) 682-6100
International Dial-in Number: (862) 255-5401
Webcast:
http://www.investorcalendar.com/IC/CEPage.asp?ID=175941
Participants are recommended to dial-in approximately 10 minutes
prior to the start of the event. A replay of the call will be
available approximately two hours after completion through
May 29, 2017. To listen to the
replay, dial (877) 481-4010 (domestic) or (919) 882-2331
(international) and use replay ID 10384. The webcast replay will be
available through August 15,
2017.
About DarioHealth
DarioHealth Corp. (NASDAQ: DRIO) is
a leading global digital health company serving tens of thousands
of users with dynamic mobile health solutions. We believe people
deserve the best tools to manage their treatment, and harnessing
big data, we have developed a unique way for our users to analyze
and personalize their diabetes management. With our smart diabetes
solution, users have direct access to track and monitor all facets
of diabetes, without having the disease slow them down. The
acclaimed Dario™ Blood Glucose Monitoring System all-in-one blood
glucose meter and native smartphone app gives users an unrivaled
method for self-diabetes management. DarioHealth is headquartered
in Caesarea, Israel with a
regional office in Burlington,
Massachusetts. For more information, visit
http://mydario.investorroom.com/.
Cautionary Note Regarding Forward-Looking Statements
This news release and the statements of representatives and
partners of DarioHealth Corp. (the "Company") related thereto
contain or may contain forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
Statements that are not statements of historical fact may be deemed
to be forward-looking statements. Without limiting the generality
of the foregoing, words such as "plan," "project," "potential,"
"seek," "may," "will," "expect," "believe," "anticipate," "intend,"
"could," "estimate" or "continue" are intended to identify
forward-looking statements. For example, when the Company
describes its growth potential, describes the expected benefits of
direct to consumer sales in Australia, and says that U.S. sales are
expected to have a significant impact on the Company's revenues and
gross margins, it is using forward-looking statements. Readers are
cautioned that certain important factors may affect the Company's
actual results and could cause such results to differ materially
from any forward-looking statements that may be made in this news
release. Factors that may affect the Company's results include, but
are not limited to, regulatory approvals, product demand, market
acceptance, impact of competitive products and prices, product
development, commercialization or technological difficulties, the
success or failure of negotiations and trade, legal, social and
economic risks, and the risks associated with the adequacy of
existing cash resources. Additional factors that could cause or
contribute to differences between the Company's actual results and
forward-looking statements include, but are not limited to, those
risks discussed in the Company's filings with the U.S. Securities
and Exchange Commission. Readers are cautioned that actual results
(including, without limitation, the timing for and results of the
Company's commercial and regulatory plans for Dario™) may differ
significantly from those set forth in the forward-looking
statements. The Company undertakes no obligation to publicly update
any forward-looking statements, whether as a result of new
information, future events or otherwise, except as required by
applicable law.
DarioHealth Corporate and Media Contact
Shmuel Herschberg
Marketing Director
shmuel@mydario.com
+1-800-896-9062
DarioHealth Investor Relations Contact
Hayden IR
Rob Fink / Brett Maas
DRIO@HaydenIR.com
+1-646-415-8972 / +1-646-536-7331
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/dariohealth-to-host-first-quarter-conference-call-on-may-15-2017-300454029.html
SOURCE DarioHealth Corp.